SCHEMBL6013166

SCHEMBL6013166

CC(C)c1cc(-c2ccc(F)cc2)cc(F)n1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.39
GCGR P47871 5/20 0.36
DRD2 P14416 1/20 0.35
HTR6 P50406 1/20 0.35
CYP17A1 P05093 1/20 0.35
ALDH1A3 P47895 1/20 0.35
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
MAPK14 Q16539 2/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8201704 0.84 ADORA2A (0.43) SCN9AGCGRMAPK14
SCHEMBL12299835 0.76 NOS3 (0.39) HTR2B
SCHEMBL17341047 0.74 MAPK10 (0.43) CYP17A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL12202948 0.71 ADORA3 (0.41) GCGRALDH1A3HTR2B
SCHEMBL12228276 0.71 KDM4E (0.45) SCN9AHTR2B
SCHEMBL28094104 0.70 NOS3 (0.44) SCN9AHTR2B
SCHEMBL2337367 0.70 ADORA3 (0.43) SCN9AGCGR
SCHEMBL3840856 0.70 AURKA (0.56) HTR2BMAPK14
SCHEMBL18086893 0.70 CYP17A1 (0.40) GCGRCYP17A1MAPK14MAPK13MAPK12
SCHEMBL16282388 0.70 NOS3 (0.57) HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1684754-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD Bristol-Myers Squibb Company (US) 2006-08-02 EP disclosed
WO-2005051386-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-09 WO disclosed